CDNA - CareDx, Inc
26.64 0.00 (0.00%)
After hours: 4:00PM EDT
| Previous Close | 27.22 |
| Open | 27.03 |
| Bid | 26.66 x 800 |
| Ask | 29.97 x 1100 |
| Day's Range | 26.48 - 27.65 |
| 52 Week Range | 19.11 - 41.27 |
| Volume | 317,348 |
| Avg. Volume | 845,687 |
| Market Cap | 1.129B |
| Beta (3Y Monthly) | 0.85 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Top Ranked Momentum Stocks to Buy for October 18th
Top Ranked Momentum Stocks to Buy for October 18th
- Simply Wall St.
We're Excited To See How CareDx (NASDAQ:CDNA) Uses Its Cash Hoard To Grow
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
- Zacks
CareDx, Inc (CDNA) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in CareDx, Inc (CDNA).
- Simply Wall St.
Who Has Been Selling CareDx, Inc (NASDAQ:CDNA) Shares?
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
- GuruFocus.com
Caredx Inc (CDNA) CEO Peter Maag Sold $1.4 million of Shares
CEO of Caredx Inc (30-Year Financial, Insider Trades) Peter Maag (insider trades) sold 50,000 shares of CDNA on 08/06/2019 at an average price of $28.84 a share. Continue reading...
- Thomson Reuters StreetEvents
Edited Transcript of CDNA earnings conference call or presentation 1-Aug-19 8:30pm GMT
Q2 2019 CareDx Inc Earnings Call
- Simply Wall St.
Is CareDx, Inc's (NASDAQ:CDNA) CEO Salary Justified?
Peter Maag became the CEO of CareDx, Inc (NASDAQ:CDNA) in 2012. This report will, first, examine the CEO compensation...
Motley FoolCareDx, Inc (CDNA) Q2 2019 Earnings Call Transcript
CDNA earnings call for the period ending June 30, 2019.
- Zacks
CareDx (CDNA) Reports Next Week: Wall Street Expects Earnings Growth
CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Motley Fool
Here's Why CareDx Stock Is Sliding Today
A fund manager betting against the diagnostics company laid out some serious allegations.
- TheStreet.com
CareDx Looks Like It Can Continue Its Impressive Rally, So Go Long
In his "Homework" segment of "Mad Money" Wednesday, Jim Cramer followed up on a few stocks that had stumped him during earlier shows. Jim said he likes the story at CareDx Inc. , a molecular diagnostics company, but that investors need to wait for a pullback in this speculative stock after it rallied 212% in the last 12 months. In this daily bar chart of CDNA, below, we can see a strong uptrend with a number of consolidations and pullbacks giving traders and investors several buying opportunities along the way.
- Zacks
Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others
President Trump signed an executive order Wednesday that will encourage an increase in kidney transplants. This transplant diagnostic company stands to grow significantly, while dialysis companies will take a hit.
- Simply Wall St.
What You Must Know About CareDx, Inc's (NASDAQ:CDNA) Beta Value
If you own shares in CareDx, Inc (NASDAQ:CDNA) then it's worth thinking about how it contributes to the volatility of...
- Insider Monkey
Hedge Funds Have Never Been This Bullish On CareDx, Inc. (CDNA)
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives us access to a wealth of collective knowledge based on these firms' portfolio holdings as of March 31. In this […]
- Simply Wall St.
Is CareDx, Inc (NASDAQ:CDNA) Trading At A 41% Discount?
How far off is CareDx, Inc (NASDAQ:CDNA) from its intrinsic value? Using the most recent financial data, we'll take a...
- Thomson Reuters StreetEvents
Edited Transcript of CDNA earnings conference call or presentation 8-May-19 8:30pm GMT
Q1 2019 CareDx Inc Earnings Call
- Motley Fool
Here's Why CareDx Stock Is Rising Today
The transplant diagnostic service provider took some important steps forward in the first quarter.
- Motley Fool
CareDx, Inc (CDNA) Q1 2019 Earnings Call Transcript
CDNA earnings call for the period ending March 31, 2019.
- Zacks
CareDx (CDNA) Q1 Earnings and Revenues Top Estimates
CareDx (CDNA) delivered earnings and revenue surprises of 350.00% and 7.07%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press
CareDx: 1Q Earnings Snapshot
On a per-share basis, the Brisbane, California-based company said it had a loss of 18 cents. Earnings, adjusted for stock option expense and non-recurring costs, came to 5 cents per share. The results ...
- Simply Wall St.
The CareDx (NASDAQ:CDNA) Share Price Is Up 580% And Shareholders Are Delighted
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Investing can be hard but the potential fo an individual stock to pay off big time inspires us...
- Zacks
CareDx (CDNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Breakeven On The Horizon For CareDx, Inc (NASDAQ:CDNA)
CareDx, Inc's (NASDAQ:CDNA): CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide...
- TechCrunch
A new lawsuit involving Stanford and Sequoia Capital highlights fights to come over cell-free DNA testing
This morning, a publicly traded transplant diagnostics company called CareDx,along with Stanford University, sued another publicly traded genetic testingcompany, Natera, for patent infringement
